Summary:
This study will be evaluating an investigational product as an add-on medicaton for bipolar I disorder in children and adolescents who continue to be symptomatic on their current medication(s). During the study, subjects will remain on current bipolar medication while receiving an investigational product in addition.
Qualified Participants Must:
• Be 10-17 years of age
•
Have a diagnosis of bipolar I disorder and currently be experiencing symptoms
•
Currently be taking bipolar medications at a stable dose for at least four weeks prior to initial study visit
•
Qualified Participants May Receive:
Study-related care, exams, and study medication at no charge, plus compensation for time and effort.